EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation

Chenzhou Wu, Xiaomin Cai, Ying Wang, Carlos D Rodriguez, Giorgia Zoaldi, Lydia Herrmann, Chun-Yuh Huang, Xiaoqiong Wang, Viraj R Sanghvi, Rongze O Lu, Zhipeng Meng

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Chenzhou Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, USA; Sylvester Comprehensive Cancer…. Hauptthemen laut MEDLINE: Hippo Signaling Pathway, Protein Serine-Threonine Kinases, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo signaling is instrumental in regulating organ size, regeneration, and carcinogenesis. The cytoskeleton emerges as a primary Hippo signaling modulator. Its structural alterations in response to environmental and intrinsic stimuli control Hippo signaling pathway activity. However, the precise mechanisms underlying the cytoskeleton regulation of Hippo signaling are not fully understood. RAP2 GTPase is known to mediate the mechanoresponses of Hippo signaling via activating the core Hippo kinases LATS1/2 through MAP4Ks and MST1/2. Here we show the pivotal role of the reciprocal regulation between RAP2 GTPase and the cytoskeleton in Hippo signaling. RAP2 deletion undermines the responses of the Hippo pathway to external cues tied to RhoA GTPase inhibition and actin cytoskeleton remodeling, such as energy stress and serum deprivation. Notably, RhoA inhibitors and actin disruptors fail to activate LATS1/2 effectively in RAP2-deficient cells. RNA sequencing highlighted differential regulation of both actin and microtubule networks by RAP2 gene deletion. Consistently, Taxol, a microtubule-stabilizing agent, was less effective in activating LATS1/2 and inhibiting cell growth in RAP2 and MAP4K4/6/7 knockout cells. In summary, our findings position RAP2 as a central integrator of cytoskeletal signals for Hippo signaling, which offers new avenues for understanding Hippo regulation and therapeutic interventions in Hippo-impaired cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hippo Signaling PathwayProtein Serine-Threonine KinasesSignal TransductionAnimalsHumansMiceCytoskeletonMicrotubulesPaclitaxelrap GTP-Binding ProteinsrhoA GTP-Binding ProteinTumor Suppressor ProteinsPhosphorylation

Stichwörter der Autor:innen

Hippo signalingMAP4KRAP2 GTPasecytoskeletonenergy stressmechanotransduction

Substanzen

LATS1 protein, humanLATS2 protein, humanPaclitaxelProtein Serine-Threonine Kinasesrap GTP-Binding ProteinsRAP2A protein, humanrhoA GTP-Binding ProteinTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida…
  • Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Biomedical Engineering, University of Miami, Coral Gables, Florida, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida,…
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York…
  • Department of Neurological Surgery, Brain Tumor Center, Helen Diller Cancer Center, UCSF, San Francisco, California, USA.

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • American Cancer Society
  • National Institute of Neurological Disorders and Stroke
  • National Cancer Institute
  • US Department of Defense
  • Sylvester Comprehensive Cancer Center

Zitieren

APA

Wu, C., Cai, X., Wang, Y., Rodriguez, C. D., Zoaldi, G., Herrmann, L., Huang, C. Y., Wang, X., Sanghvi, V. R., Lu, R. O., & Meng, Z. (2024). Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107257

Vancouver

Wu C, Cai X, Wang Y, Rodriguez CD, Zoaldi G, Herrmann L, et al. Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107257

BibTeX
@article{Wu2024,
  author = {Wu, Chenzhou and Cai, Xiaomin and Wang, Ying and Rodriguez, Carlos D and Zoaldi, Giorgia and Herrmann, Lydia and Huang, Chun-Yuh and Wang, Xiaoqiong and Sanghvi, Viraj R and Lu, Rongze O and Meng, Zhipeng},
  title = {Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107257}
}
Kostenlos starten →